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ABSTRACT 
 
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality 
worldwide, accounting for about 9.6 million new cases and 1.5 million deaths 
annually. Multidrug resistant tuberculosis (MDR-TB), defined as resistance to, at 
least, rifampin and isoniazid (the recommended first-line therapeutic regimen), 
represents another important threat in the fight against the disease. Approximately 
480,000 newly emerging cases of MDR-TB are estimated to occur every year. The 
spread of MDR-TB mostly derives from mismanagement of TB cases such as the 
use of inappropriate dosage, inappropriate regimen, limited availability of quality 
assured pharmaceutical products, and little effort to support patient adherence. 
This study aimed to examine the determinants of delayed MDR-TB diagnosis and 
treatment in Surakarta, Central Java. 
Subjects and Method: This was a cross sectional study conducted at Dr. 
Moewardi Hospital, Surakarta, Central Java. A total of 73 MDR-TB patients were 
selected for this study. The dependent variable was delayed MDR-TB diagnosis and 
treatment. The independent variables were age, gender, distance to health facility, 
health facility type, suspect criteria of MDR-TB. Data on MDR-TB were taken from 
medical record. The other data were collected by questionnaire and analyzed by a 
multiple logistic regression.  
Results: Delayed MDR-TB diagnosis was associated with age (OR= 1.02; 95% CI= 
0.98 to 1.06; p= 0.330), gender (OR= 0.06; 95% CI= 0.19 to 1.75 p= 0.330), dis-
tance to health facility (OR=1.50; 95% CI= 0.53 to 4.19; p= 0.450), health facility 
type (OR= 0.97; 95% CI= 0.49 to 1.92; p= 0.920), and MDR-TB suspect criteria 
(OR= 0.91;  95% CI= 0.61 to 1.35; p= 0.620), but none of them was statistically 
significant. Delayed MDR-TB treatment was associated with age (OR= 0.99; 95% 
CI= 0.96 to 1.03; p= 0.870), gender (OR= 0.42; 95% CI= 0.15 to 1.22; p= 0.112), 
distance to health facility (OR= 1.2; 95% CI= 0.44 to 3.30; p= 0.730), health facility 
type (OR= 1.50; 95% CI= 0.77 to 2.92; p= 0.240), and MDR-TB suspect criteria 
(OR= 0.90; 95% CI= 0.62 to 1.32; p= 0.600), but none of them was statistically 
significant. 
Conclusion: Age, gender, distance to health facility, health facility type, and 
MDR-TB suspect criteria, can not be used as reliable predictors of delayed MDR-
TB diagnosis and treatment. 
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